Kwality Pharmaceuticals Ltd

₹ 908 0.35%

28 Oct - close price

About

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products^[1]

Key Points

Business Overview:^[1]^[2]
KPL is in an ANVISA and EU GMP certified manufacturer of all pharma products including complex molecules across all dosage forms including niche Biologics. It has a portfolio of 3000+ formulations across 25+ therapeutic areas with categories including generics, cephalosporin, beta-lactam, oncology & biologics. It manufactures and deals in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations

Website BSE

Market Cap ₹ 942 Cr.
Current Price ₹ 908
High / Low ₹ 1,235 / 596
Stock P/E 21.7
Book Value ₹ 254
Dividend Yield 0.00 %
ROCE 18.4 %
ROE 16.3 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 15.5%
Company's median sales growth is 22.4% of last 10 years

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 152 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	70	56	56	69	67	70	78	92	80	90	84	116	111
	52	40	41	57	54	54	61	71	63	70	67	90	87
Operating Profit	18	16	15	11	14	15	17	21	17	20	18	26	24
OPM %	26%	28%	27%	17%	20%	22%	21%	22%	22%	22%	21%	22%	22%
	0	1	0	-15	0	0	1	-7	0	0	1	1	0
Interest	1	1	2	2	2	2	3	3	2	3	2	2	3
Depreciation	3	4	4	4	5	5	5	5	4	5	5	5	5
Profit before tax	14	12	10	-10	7	8	10	6	11	13	11	19	17
Tax %	25%	19%	28%	-24%	25%	24%	21%	29%	25%	33%	25%	24%	30%
	11	9	7	-7	5	6	8	4	8	8	9	14	12
EPS in Rs	10.16	9.08	6.84	-7.11	5.22	6.01	7.41	4.20	8.06	8.16	8.22	13.96	11.50
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	60	52	74	98	137	166	139	262	456	251	307	370	402
	56	49	69	89	126	150	125	233	285	190	241	290	314
Operating Profit	4	3	5	9	12	16	14	29	172	61	66	80	87
OPM %	6%	6%	7%	9%	8%	9%	10%	11%	38%	24%	22%	22%	22%
	0	0	0	1	1	1	4	2	4	-14	-5	2	2
Interest	1	1	1	2	2	2	3	3	3	7	10	10	10
Depreciation	1	1	2	3	3	3	4	6	11	15	20	18	19
Profit before tax	2	1	2	6	7	11	11	21	162	26	31	54	60
Tax %	47%	41%	48%	42%	39%	31%	25%	30%	26%	25%	24%	26%
	1	1	1	3	4	8	8	15	120	19	24	40	43
EPS in Rs	0.93	0.92	1.55	3.23	4.39	7.28	8.02	14.60	115.64	18.67	22.94	38.41	41.84
Dividend Payout %	0%	0%	0%	9%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	22%
5 Years:	22%
3 Years:	-7%
TTM:	26%

Compounded Profit Growth
10 Years:	46%
5 Years:	37%
3 Years:	-31%
TTM:	36%

Stock Price CAGR
10 Years:	%
5 Years:	73%
3 Years:	34%
1 Year:	12%

Return on Equity
10 Years:	27%
5 Years:	29%
3 Years:	16%
Last Year:	16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4	4	5	5	10	10	10	10	10	10	10	10
Reserves	13	15	17	20	19	27	36	51	171	190	214	254
	6	8	13	19	26	29	35	41	54	90	98	112
	12	10	17	26	40	39	52	64	105	70	72	71
Total Liabilities	35	37	51	71	96	105	133	166	341	361	394	447
	13	13	13	17	20	29	43	57	92	120	139	146
CWIP	0	0	0	0	0	0	0	3	12	14	0	0
Investments	1	1	2	4	5	5	4	5	0	0	0	0
	22	24	37	50	70	71	86	102	237	226	255	302
Total Assets	35	37	51	71	96	105	133	166	341	361	394	447

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-1	1	-3	4	-1	14	6	27	61	41	43	53
	-3	-1	-2	-7	-6	-12	-18	-23	-63	-48	-26	-29
	3	1	6	5	5	-2	12	1	6	1	-17	-14
Net Cash Flow	-1	1	0	2	-1	-0	0	4	3	-6	-1	10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	41	63	89	84	98	84	79	50	55	104	136	152
Inventory Days	58	61	67	71	54	34	94	38	97	310	187	167
Days Payable	58	40	63	65	80	52	96	58	63	117	106	112
Cash Conversion Cycle	42	85	93	90	73	67	77	30	90	297	217	208
Working Capital Days	61	35	41	20	18	20	43	24	60	118	101	98
ROCE %		9%	13%	19%	19%	22%	18%	26%	98%	19%	16%	18%

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	54.44%	54.73%	54.73%	54.76%	54.76%	54.82%	54.82%	54.82%	54.82%	54.82%	54.82%	54.82%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.02%	0.03%	0.32%	0.33%	0.33%
	45.54%	45.25%	45.25%	45.22%	45.22%	45.17%	45.18%	45.15%	45.14%	44.86%	44.86%	44.83%
No. of Shareholders	5,376	6,211	6,943	6,291	5,786	5,695	5,273	7,487	8,947	9,420	10,115	11,595

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
	50.14%	50.14%	50.14%	51.52%	54.13%	54.43%	54.73%	54.82%	54.82%	54.82%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.32%	0.33%
	49.86%	49.86%	49.86%	48.48%	45.87%	45.57%	45.25%	45.17%	44.86%	44.83%
No. of Shareholders	147	198	180	157	148	581	6,211	5,695	9,420	11,595

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Credit ratings

Concalls

Jun 2025

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
Aug 2023

Transcript

Notes
PPT
May 2022

Transcript

Notes
PPT